Artificial micro-gland

• US 20100255059A1
• Filed: 03/17/2010
• Published: 10/07/2010
• Est. Priority Date: 04/02/2009
• Status: Abandoned Application

• Current Assignee: Manuel Marquez, Samantha M. Marquez
• Original Assignee: Ynano LLC
• Inventors: Garcia, Antonio, Marquez, Samantha M., Marquez, Manuel
• Application Number:
  US12/726,158
• Publication Number:
  US 20100255059A1
• Time in Patent Office: Days
• US Class Current: 424/424
• CPC Class Codes: A61F 2/022 Artificial gland structures using bioreactors hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36
• CPC Class Codes: A61K 35/28 Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
• CPC Class Codes: A61K 35/36 Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells islets of Langerhans A61K35/39
• CPC Class Codes: A61K 35/39 Pancreas; Islets of Langerhans Langerhans cells of epidermis A61K35/36
• CPC Class Codes: A61K 35/54 Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
• CPC Class Codes: A61L 2400/12 Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
• CPC Class Codes: A61L 27/3804 characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
• CPC Class Codes: A61L 27/60 Materials for use in artificial skin
• CPC Class Codes: A61P 5/00 Drugs for disorders of the endocrine system
• CPC Class Codes: C12N 5/0062 General methods for three-dimensional culture

Abstract

A micro-scale artificial gland is disclosed in the form of an independent unit for promoting biological activity. The artificial gland includes cells formed in a membrane enclosing a reservoir. The reservoir is a bio-reactor capable of containing a product of activity of the cells. The reservoir comprises a gas, a liquid, and a gel and preferably also contains nanoparticles, a buffer, a surfactant, and, a gel precursor. The reservoir may also contain cells. Nanoparticles may also surround the artificial gland to form a protective coating. A variety of methods are disclosed for making the artificial gland by directed assembly of cells into the artificial micro-gland by gel, liquid or bubble templating. All involve coating the surface of gel, droplet or bubble with the living cells and the stabilizing the cells on the surface of gels, droplets or bubbles.

Claims

1. An artificial gland that is an independent unit for promoting biological activity, the artificial gland comprising:

cells assembled in three dimensions and organized to form a membrane, the membrane configured to define an enclosed volume; and

,

a reservoir within the enclosed volume, the reservoir comprising a bio-reactor capable of containing a product of activity of the cells.

2. The artificial gland of claim 1, wherein the bio-reactor comprises a substance selected from the group consisting of a gas, a liquid, and a gel.

3. The artificial gland of claim 1, wherein the artificial gland has a dimension not exceeding 500 microns.

4. The artificial gland of claim 1, wherein the cells are selected from the group consisting of stem cells, mesenchymal cells, embryonic cells, hybridomes B, hybridomes T, differentiated cells, tumor cells, cancer cells, skin cells, neural tube cell derivatives, astrocytes, olygodendrocytes, neuron, muscle cells, myocytes, myocardiocytes, leiomyocytes, epithelial cells, endothelium cells, endocrine gland cells, immune system cells, phagocytes, macrophages, lymphocytes, white cells, thrombocytes, platelets, erythrocytes, red cells, neutrophils, mastocytes, eosinophils, hematopoietic precursor cells, cells from a erytocyte line, proerytroblast, erythroblast basophil, erythroblast polychromatophilo, erythroblast orthochromatic, reticulocyte, erytrocyto, cells from a myeloid line, myeloblast, promyelocyte, myelocyte, metamyelocyte, neutrophil, eosinophil, basophilo, lymphocitic line, lymphoblast, prolymphocyte, lymphocyte, monocytic line, monoblast, promonocyte, monocyte, megakaryocyte, megakaryoblast platelets, promegakaryocyte platelets, megakaryocyte platelets, cells from a plasmatic line, B cell, plasmoblast, proplasmocyte, plasmocyte, hepatocytes, hystiocytes, microglia cells, fibroblasts, adipocytes, reticulocytes, chondrocytes, chondroblasts, osteocytes, osteoblasts, osteoclasts, cells with cilli, cells with flagellum, cells from a germinal cell line, cells from a ovogonia cell line, cells from a spermatogonian line, pneumocytes kind I and II, kidney cells, nephroblasts, retinocytes, retinoblasts, and oligodendrocytes.

5. The artificial gland of claim 1, wherein the reservoir is further comprising:

nanoparticles that are biocompatible, tend to affix to the surface of the cells when in the aqueous solution, create a cation when exposed to an acid, and have physical and chemical characteristics that allow their removal from the cells without destroying all of the cells;

a buffer that maintains a constant pH of the aqueous solution;

a surfactant that stabilizes droplets comprising the aqueous solution from coalescing upon contact; and

,

a gel precursor that reacts with the cation to form a gel.

6. A method of making the artificial gland of claim 5 using a droplet and controlled gelation, the method comprising the steps of:

producing an aqueous solution comprising;

cells;

nanoparticles that are biocompatible, tend to affix to the surface of the cells when in the aqueous solution, create a cation when exposed to an acid, and have physical and chemical characteristics that allow their removal from the cells without destroying all of the cells;

a buffer that maintains a constant pH of the aqueous solution;

a buffer that maintains a constant pH of the aqueous solution;

a surfactant that stabilizes droplets comprising the aqueous solution from coalescing upon contact; and

,

a gel precursor that reacts with the cation to form a gel;

injecting the aqueous solution in a microchannel;

adding inert oil to the microchannel at an injection port, wherein the injection port is configured so that the oil separates the aqueous solution into droplets;

collecting the droplets in a container;

adding acid to the container to reduce the pH of the droplets, wherein the acid is miscible in the inert oil and the droplets, and wherein the acid initiates gelation inside each droplet and forms the artificial gland within each droplet;

removing the inert oil from the container;

adding a salt to the container to deactivate the surfactant and release each artificial gland from within its droplet; and

,

rinsing the artificial glands to remove the salt and the deactivated surfactant from the container.

7. The artificial gland of claim 1, wherein the reservoir is further comprising cells.

8. The artificial gland of claim 1, further comprising nanoparticles surrounding the artificial gland to form a second membrane and protective covering over the artificial gland wherein the nanoparticles are biocompatible, tend to affix to the surface of the cells when in an aqueous solution, create a cation when exposed to an acid, and have physical and chemical characteristics that allow their removal from the cells without destroying all of the cell.

9. A method of making the artificial gland of claim 8, the method comprising the steps of:

combining cells and nanoparticles in water wherein the nanoparticles are configured to;

migrate to the cells and homogenously surround each cell in the aqueous solution forming a membrane of nanoparticles;

be compatible with the cells such that while surrounding each cell preserves their viability;

removing the water to produce product cells each having a shell of nanoparticles;

adding an inert oil as a carrier fluid;

flowing the product cells and carrier fluid in a microchannel toward an intersecting microchannel;

flowing a discrete volumetric packet in a second microchannel toward the intersecting microchannel so as to collide with the product cells and allow product cells to assemble and organize on the surface of the discrete volumetric packet, wherein the discrete volumetric packet is the selected from the group consisting of a gas, a liquid, a gel, and volvox algae.

10. The method of claim 9, further comprising the step of adding a buffer to the water, cells and nanoparticles to maintain a constant pH of the combination.

11. The method of claim 9, further comprising the step of charging the product cells and the discrete volumetric packet with opposite electrical charges.

12. A method of using the artificial gland of claim 1 comprising the step of depositing a plurality of artificial glands on a template comprising collagen, procollagen, elastin, fibronectin, laminin, alginate, alginate and polycations shell (poly L lysine, ornithine, chitosan, peg, poli metilen co guanidine, poly etilen amine, poteroglycans, heparin-sulfate, chondroitin-sulfate, keratin sulfate, polyacrylates, polyglicocolic acid, polyglicocolic acid and lactic acid, K-carrageenan, agarose, damaged tissues, artificial bone, and artificial muscle.

13. A method of making the artificial gland of claim 1 using two droplets with one of the droplets comprising cells, the method comprising the steps of:

producing a first droplet in an inert oil carrier fluid, the first droplet comprising cells in a first aqueous medium and a surfactant that stabilizes first droplets from coalescing with each other upon contact;

producing a second droplet in an inert oil carrier fluid, the second droplet comprising a second aqueous medium, calcium carbonate nanoparticles, a gel precursor, and a surfactant that stabilizes second droplets from coalescing with each other upon contact;

wherein the first droplet or the second droplet further comprises a buffer that maintains a constant pH of the first aqueous medium or the second aqueous medium, respectively;

charging the first droplet and the second droplet with opposite electrical charges;

combining the first droplet with the second droplet by colliding them together in a microchannel to produce a third droplet;

collecting the third droplet in a container;

adding acid to the container to reduce the pH of the third droplet, wherein the acid is miscible in the inert oil carrier fluid and the first aqueous medium and the second aqueous medium, and wherein the acid initiates gelation inside each third droplet and forms the artificial gland within each third droplet;

removing the inert oil from the container;

adding a salt to the container to deactivate the surfactant and release the artificial gland from within the third droplet; and

,

rinsing the artificial gland to remove the salt and the deactivated surfactant from the container.

14. A method of making artificial gland of claim 1, the method employing a plurality of types of cells in the membrane, the method comprising the steps of:

flowing, in a first microchannel, a first artificial gland carrying an electric charge, the first artificial gland comprising;

a first reservoir comprising a biocompatible liquid; and

,

a first membrane comprising a plurality of cells of a first type surrounding the first reservoir;

flowing, in a second microchannel, a second artificial gland carrying an electric charge opposite to that of the first artificial gland, the second artificial gland comprising;

a second reservoir comprising a second biocompatible liquid; and

,

a second membrane surrounding the second reservoir wherein the second membrane comprises cells of a second type;

contacting the first artificial gland with the second artificial gland upon their flowing to a junction connecting the first microchannel and the second microchannel, said junction comprising a main microchannel; and

,

producing a third artificial gland by merging the first artificial gland and the second artificial gland using electrocoalescence, wherein the third artificial gland comprises a membrane with a first discrete section comprising the cells of the first type and a second discrete section comprising the cells of the second type.

15. The method of claim 14, wherein the first reservoir further comprises a plurality of cells.

16. The method of claim 14, wherein the first membrane further comprises a plurality of cell types.

17. The method of claim 14, further comprising the step of stacking a plurality of third artificial glands into a macroscopic network of close-packed arrays.

18. The method of claim 17, further comprising the step of adding material to the macroscopic network, said material selected from the group consisting of a nutrient, a protein, a collagen, fibrinogen, elastin, a synthetic biocompatible polymer, a pharmaceutical product, a perfluorinated compound, and a biopolymer.

19. The method of claim 14, wherein using electrocoalescence comprises subjecting the first artificial gland and the second artificial gland to an electric field.

20. A method of making the artificial gland of claim 1 comprising the steps of:

preparing an aqueous culture medium comprising cells, polymers, and a protein composition;

injecting the aqueous culture medium into fluorinated oil to form a suspension of discrete droplets of the aqueous culture medium;

forming a polymer monolayer on the surface of the droplet to form the artificial gland; and

,

rinsing the suspension to produce isolated artificial glands.

21. A method of making the artificial gland of claim 1 comprising the steps of:

preparing an aqueous culture medium comprising polymers, and a protein composition;

injecting the aqueous culture medium into fluorinated oil to form a suspension of discrete droplets of the aqueous culture medium;

forming a polymer monolayer on the surface of the droplet;

injecting cells into the suspension for assembly on the surface of the droplet to form the artificial gland; and

,

rinsing the suspension to produce isolated artificial glands.

22. A method of making the artificial gland of claim 1 comprising the steps of:

preparing a first aqueous culture medium comprising polymers, and a protein composition;

injecting the first aqueous culture medium into fluorinated oil to form a suspension of first droplets of the aqueous culture medium;

forming a polymer monolayer on the surface of the first droplets;

producing second droplets in an inert oil carrier fluid, the second droplet comprising cells in a second aqueous medium and a surfactant that stabilizes droplets comprising the second aqueous solution from coalescing upon contact;

charging the first droplets and the second droplets with opposite electrical charges;

combining one of the first droplets with one of second droplets by colliding them together in a microchannel to produce a third droplet;

collecting the third droplet in a container;

adding acid to the container to reduce the pH of the third droplet,

wherein the acid is miscible in the inert oil carrier fluid, the first aqueous medium and the second aqueous medium; and

,

wherein the acid initiates gelation inside the third droplet and forms the artificial gland within the third droplet;

removing the inert oil from the container;

adding a salt to the container to deactivate the surfactant and release the artificial gland from within the third droplet; and

,

rinsing the artificial gland to remove the salt and the deactivated surfactant from the container.

23. A method of making the artificial gland of claim 1 comprising the steps of:

creating a suspension of nanoparticles in an inert fluorocarbon oil;

flowing a fluid in a microchannel, wherein the fluid is selected from the group consisting of a gas, a liquid, and a gel;

introducing the suspension into the microchannel to form a discrete volumetric packet of the fluid;

producing a stabilized discrete volumetric packet comprising a layer of nanoparticles on the surface of the discrete volumetric fluid; and

,

adding cells to the stabilized discrete volumetric packet so that the cells assemble in three dimensions and organize to form a membrane covering the discrete volumetric packet to produce the artificial gland.

24. A method of making the artificial gland of claim 1 comprising the steps of:

preparing individual aqueous droplets comprising water dispersed in inert oil and a surfactant;

charging the individual aqueous droplets with an electric charge;

flowing the aqueous droplets into a first microchannel;

flowing cells carrying an electric charge opposite to the electric charge of the droplets into a second microchannel that intersects with the first microchannel;

combining the droplets with the cells by colliding them together in a microchannel to produce a second droplet;

collecting the second droplet in a container;

adding acid to the container to reduce the pH of the second droplet,

wherein the acid is miscible in the inert oil and the water, and,

wherein the acid initiates gelation inside each second droplet and forms the artificial gland within each second droplet;

removing the inert oil from the container;

adding a salt to the container to deactivate the surfactant and release the artificial gland from within the third droplet; and

,

rinsing the artificial gland to remove the salt and the deactivated surfactant from the container.

25. A method of making the artificial gland of claim 1 using a double emulsion, the method comprising the steps of:

mixing silicon oil and sodium alginate to form a first emulsion having a pH of less than 7;

mixing cells and calcium carbonate nanoparticles in water to form a second emulsion;

mixing the first emulsion with the second emulsion a carrier fluid to form a double emulsion; and

,

mixing ABIL-EM 90 polymeric surfactant in the double emulsion.

26. The method of claim 25, further comprising the step of adding cell growth medium, collagen and fibronectin monomers to the second emulsion.

27. The method of claim 25, further comprising the steps of:

pre-emulsifying the silicon oil in an aqueous solution of thrombin; and

,

adding fibrinogen monomers to the second emulsion.

28. The method of claim 25, further comprising the step of adding poly-NIPAM microgels in the first emulsion.

29. The method of claim 25, further comprising the steps of:

dissolving a small amount of sodium-acetate in the silicon oil of the first emulsion; and

,

adding cell growth medium, sodium alginate and calcium carbonate nanocrystals to the second emulsion.

30. The method of claim 25, further comprising the steps of:

incubating the cells in growth medium supplemented with biocompatible cationic polymers; and

,

adding a biocompatible anionic surfactant to the first emulsion.

31. An artificial gland of micro-scale for promoting biological activity, the artificial gland comprising:

biological units assembled in three dimensions and organized to form a membrane, the membrane configured to define an enclosed micro-scale volume; and

,

a reservoir within the enclosed micro-scale volume, the reservoir comprising a bio-reactor capable of containing a product of activity of the biological units, wherein the reservoir comprises a substance selected from the group consisting of a gas, a liquid, and a gel.

32. The artificial gland of claim 31 wherein the biological units are selected from the group consisting of:

fungi, algae, spores, pollen, yeast, bacteria, and viruses.

33. An artificial gland of micro-scale for promoting biological activity, the artificial gland comprising:

components of a cell assembled in three dimensions and organized to form a membrane, the membrane configured to define an enclosed micro-scale volume; and

,

a reservoir within the enclosed micro-scale volume, the reservoir comprising a bio-reactor capable of containing a product of activity of the components of a cell, wherein the reservoir comprises a substance selected from the group consisting of a gas, a liquid, and a gel.

34. The artificial gland of claim 33 wherein the components of a cell are selected from the group consisting of:

enzymes, prions, hormones, growth factors, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-beta, cytokines, interleukins, albumin-scavengers, polyclonal-anti-bodies, monoclonal-anti-bodies, immunoglobulins, protease enzymes, lysosomes, vesicles, cell membranes, rough endoplasmic reticulums, smooth endoplasmic reticulums, mitochondria, ribosomic ribonucleic acid, transference ribonucleic acid, deoxyribonucleic acid, microtubules, endocrine cells, and human T-cells, fatty acids, beta-OH-butyrate, aceto acetate, polycations, poly L lysine, ornithine, chitosan, oligoelements, genes, chloroplasts, chlorophyll, glucidic elements.

35. An artificial gland that is an independent micro-scale unit for promoting biological activity, the artificial gland comprising:

cells assembled in three dimensions and organized to form a membrane, the membrane configured to define an enclosed micro-scale volume; and

,

a reservoir within the enclosed micro-scale volume, the reservoir comprising volvox algae.

36. An artificial gland that is an independent micro-scale unit for promoting biological activity, the artificial gland comprising:

cells assembled in three dimensions and organized to form a membrane, the membrane configured to define an enclosed micro-scale volume; and

,

a reservoir within the enclosed micro-scale volume, the reservoir comprising an organized algae micro-colony selected from the group consisting of diatoms, cyanobacteria, pediastrum, hydrodictyon, chlorella, paramecium bursania, Haematococcus pluvialis, spirogyra, mougeotia and zygnema.